Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Clinical potential of SLAMF7 antibodies - focus on elotuzumab in multiple myeloma.
PropertyValue
has major subject area list Antibodies, Monoclonal, Humanized; Multiple Myeloma; Signaling Lymphocytic Activation Molecule Family
information resource reference Friend R, Bhutani M, Voorhees PM, Usmani SZ. Clinical potential of SLAMF7 antibodies - focus on elotuzumab in multiple myeloma. Drug Des Devel Ther. 2017; 11:893-900.
label Clinical potential of SLAMF7 antibodies - focus on elotuzumab in multiple myeloma.
Search Criteria
  • Multiple Myeloma